Navigation Links
Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose
Date:8/28/2008

n -- warfarin -- yet, on the other hand, it remains under-used in people who would benefit most from it," Gladstone said.

The study authors believe that efforts are needed to educate physicians and patients about the benefits of warfarin therapy for those with atrial fibrillation. "This is a public health priority, because atrial fibrillation is one of the most common causes of stroke," Gladstone said. "Many more strokes could be prevented if anti-coagulation therapy were optimized in the population at large."

Dr. Byron Lee, an assistant professor of cardiology at the University of California, San Francisco, thinks part of the problem may owe to the fact that many patients have problems taking warfarin, because it requires blood tests to monitor its effectiveness. Too low a dose is ineffective, while too high a dose can cause internal bleeding. So, patients need to have their warfarin levels measured at least once a month, he said.

"Patients hate taking warfarin, and doctors hate prescribing it," Lee said. "This is mainly because it's a hassle. However, this study confirms that many strokes can be avoided if patients are adequately anti-coagulated. Therefore, both patients and doctors need to do a better job of overcoming the inconvenience of warfarin."

Dr. John Worthington is a stroke physician at Liverpool and Northern Beaches Hospitals at the University of New South Wales in Sydney, Australia, who wrote an accompanying editorial in the journal. He said it's essential for patients with atrial fibrillation to receive warfarin to prevent a stroke.

"Warfarin is usually the best and safest available treatment to prevent stroke in people with atrial fibrillation. Increasing the uptake of warfarin would reduce the risk of death and disability of stroke," he said.

Worthington said patients with AF should ask their doctor why they aren't being prescribed warfarin.

More information


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Thousands of California Healthcare Workers Strike to Protect Their Patients
2. Heart attack patients who stop statin risk death, say McGill researchers
3. After Fits and Starts, New Hope for Psoriasis Patients
4. Brain surgery is getting easier on patients
5. Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome
6. Older Patients Less Likely to Be Taken to Trauma Centers
7. Olympic Gold Medalist Inspires Cancer Patients Through Blog
8. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
9. XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntingtons Disease
10. Hope for patients with COPD
11. Prototype test for predicting clinical outcome for melanoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... (PRWEB) May 28, 2015 Real Time ... lotion and products, today announced their best-selling lotion is now ... Time Pain Relief is an FDA registered OTC pain relief ... herbal ingredients, such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu ... level of Menthol – only 1.25% – to avoid buildup ...
(Date:5/28/2015)... May 28, 2015 Hexagon Geospatial is ... , a provider of engineering, spatial data and mapping ... analyze thousands of point clouds for urban change assessments ... to 2014, the BHI Spatial Data Division implemented a ... stereo aerial imagery. Collected by a variety of different ...
(Date:5/28/2015)... IL (PRWEB) May 28, 2015 Cancer ... program exhibited improvements in physical activity, fitness and quality ... Irwin of Yale Cancer Center and Jennifer Ligibel, MD, ... Women’s Cancers, Dana Farber Cancer Institute. The findings will ... Clinical Oncology (ASCO) Annual Meeting in Chicago. ...
(Date:5/28/2015)... May 28, 2015 The MIT Sloan ... study featuring Healthcare IQ. Members of the MIT CISR ... management team to develop the case study about Healthcare ... analytics. , The case study, ‘Healthcare IQ: Competing as ... from its beginning as a hospital financial software provider ...
(Date:5/28/2015)... Dallas urologist Mark Allen, MD has ... education website NORTHTEXASUROLOGIST.COM developed by eMedical ... access current educational information on various urological concerns ... prostate cancer treatment, robotic surgery and female urinary ... educate patients on urological conditions and treatments, enabling ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2
... embarks on one of its top priorities--reforming the nation,s health care ... of Health Care Reform, which will be announced during a media ... , ... Washington, DC (Vocus) February 6, 2009 -- As ...
... The Pink Frister on The Pacific Edge is set for ... Lucy, CEO of Code Pink Boot Camp, is pleased to ... event benefiting Fristers, a non-profit that supports teen and young ... 28 at 4:00pm at the Pacific Edge Hotel in Laguna ...
... "Psoriasis Cure Now," a nonprofit patient advocacy organization, ... help everyday Americans interested in medical research be heard ... powerful lobbyists and special interests. The Web site ... make biomedical research a meaningful part of any stimulus ...
... whether people were scanned or not , , FRIDAY, Feb. 6 ... low back pain that has no apparent underlying cause doesn,t ... that doctors should not conduct routine MRI, CT or radiography ... authors say. , Dr. Roger Chou, of the Oregon Health ...
... skepticism correlate with lower cancer screening rates , , FRIDAY, ... women, have more distrust of the medical system, which ... research shows. , Almost half of all women agreed ... health-care organizations." Eighteen percent strongly agreed with the statement. ...
... Institute for Palliative Medicine,s Fellowship Program received full accreditation ... -- the first accredited fellowship program in palliative medicine ... Diego Hospice, The Institute for Palliative Medicine has trained ... Medicine is known as one of the most clinically ...
Cached Medicine News:Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 2Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 3Health News:Code Pink Boot Camp Supports Fristers and Young Mothers 2Health News:Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill 2Health News:Imaging of Low Back Pain Fails to Change Outcomes 2Health News:Minorities Distrust Medical System More 2Health News:Minorities Distrust Medical System More 3Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 2Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 3
(Date:5/28/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/rjpc7h/2015_strategies ... "2015 Strategies in the US Ancillary Hospital Locations ... to their offering. This new 973-page ... of the diagnostic testing markets outside the main ... includes analysis of the market dynamics, size, growth, ...
(Date:5/28/2015)... May 28, 2015  Freedom Meditech, Inc., a medical ... diseases from current blood-based standards to early and non-invasive ... million in a Series C financing. The company seeks ... million since founded. The company has also appointed Mr. ... a member of the company,s board of directors. Mr. ...
(Date:5/28/2015)... , May 28, 2015  According to Kalorama Information, ... Omnicare for approximately $12.7 billion fits a prevailing trend ... from an aging population. The U.S. long term care ... to continue as the aging population increases demand for ... The healthcare market researcher,s report, The Long Term ...
Breaking Medicine Technology:Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 2Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 3Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 4
... - Millennium on track to file sNDA in ... 18 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... large, international Phase III VISTA(1) trial in,patients with ... of,VELCADE, melphalan and prednisone (VMP) demonstrated a highly ...
... 10 minutes - - Landmark Study Reported in ... 18 A landmark publication that,appeared in the Journal ... site blinded clinical study. The paper is entitled "The ... Accuracy of,Melanoma and Equivocal Melanocytic Lesions." The study, ...
Cached Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 2Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 3
Ice block will provide sufficient cooling for most normal blotting applications. Sealed block is held submerged in transfer buffer. Ice block will not spill during refreezing....
... Downward Transfer Kit High resolution ,transfer of ... Rapid ,Unique downward capillary transfer allows ... neutral ,(SSC) transfers in three hours. , ... less buffer and blotting paper. Convenient refill ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
Medicine Products: